Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: A prospective randomized trial

Anesthesia and Analgesia

Volumn 108, Issue 1, 2009, Pages 30-36

  Schramko, Alexey A ^a   Suojaranta Ylinen, Raili T ^a   Kuitunen, Anne H ^a   Kukkonen, Sinikka I ^a   Niemi, Tomi T ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALBUMIN; HEPARIN; HETASTARCH; NORADRENALIN; ALBUMINOID; PLASMA SUBSTITUTE;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOLYSIS; HEART SURGERY; HEMOSTASIS; HUMAN; INTENSIVE CARE UNIT; LOW DRUG DOSE; MALE; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; THROMBOELASTOGRAPHY; TUBE; AGED; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; TIME;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; BLOOD COAGULATION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HETASTARCH; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; THROMBELASTOGRAPHY; TIME FACTORS;

EID: 58749083946     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31818c1282     Document Type: Article

References (31)

1. Boldt J, Knothe C, Zickmann B, Andres P, Dapper F, Hempelmann G. Influence of different volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 1993;76:1185-90
2. Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, Bepperling F. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000;47:1207-15
3. Karanko MS, Klossner JA, Laaksonen VO. Restoration of volume by crystalloid versus colloid after coronary artery bypass: hemodynamics, lung water, oxygenation, and outcome. Crit Care Med 1987;15:559-66
4. Verheij J, van Lingen A, Beishuizen A, Christiaans HM, de Jong JR, Girbes AR, Wisselink W, Rauwerda JA, Huybreqts MA, Groeneveld AB. Cardiac response is greater for colloid than saline fluid loading after cardiac or vascular surgery. Intensive Care Med 2006;32:1030-8
5. Niemi TT, Kuitunen AH. Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthiol Scand 1998;42:1104-9
6. Vogt NH, Bothner U, Lerch G, Lindner KH, Georgieff M. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesth Analg 1996;83:262-8
7. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a metaanalysis for postoperative bleeding. Ann Thorac Surg 2001;72: 527-33
8. Jones SB, Whitten CW, Despotis GJ, Monk TG. The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesth Analg 2003;96:363-8
9. Finfer S, Bellomo R, McEvoy S, Lo SK, Myburgh J, Neal B, Norton R. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 2006;333:1044
10. Despotis G, Avidan MS, Hogue CW. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001;72:1821-31
11. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg 2006;102:998- 1006
12. Nielsen VG, Lyerly RT III, Gurley WQ. The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation. Anesth Analg 2004;99:1587-92
13. Niemi TT, Schramko AA, Kukkonen SI, Kuitunen AH, Suojaranta-Ylinen RT. Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. Scand J Surg 2008;97:259-65
14. Saxena N, Chauhan S, Ramesh GS. A comparison of hetastarch, albumin and Ringer lactate for volume replacement in coronary artery bypass surgery. J Anaesth Clin Pharm 1997;13:117-20
15. Kuitunen AH, Heikkilä LJ, Salmenperä MT. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation. Ann Thorac Surg 1997;63:438-44
16. Boldt J, Suttner S. Plasma substitutes. Review. Minerva Anestesiol 2005;71:741-58
17. Boldt J, Schölhorn T, Mayer J, Piper S, Suttner S. The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery. Anesth Analg 2006;103:191-9
18. Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. Br J Anaesth 2002;89: 722-8
19. Nielsen VG. Effects of Hextend hemodilution on plasma coagulation kinetics in the rabbit: role of factor XIII-mediated fibrin polymer crosslinking. J Surg Res 2006;132:17-22
20. Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005;49:1163-71
21. Boldt J, Wolf M, Mengistu A. A new plasma-adapted hydroxyethylstarch preparation: in vitro coagulation studies using thrombelastography and whole blood aggregometry. Anesth Analg 2007;104:425-30
22. Van der Linden P, Ickx BE. The effects of colloid solutions on hemostasis. Can J Anaesth 2006;53:30-9
23. Omar MN, Shouk TA, Khaleq MA. Activity of blood coagulation and fibrinolysis during and after hydroxyethyl starch (HES) colloidal volume replacement. Clin Biochem 1999;32:269-74
24. Kuitunen AH, Suojaranta-Ylinen RT, Kukkonen SI, Niemi TT. Tranexamic acid does not correct the haemostatic impairment caused by hydroxyethyl starch (200 kDa/0.5) after cardiac surgery. Blood Coagul Fibrinolysis 2006;17:639-45
25. Forestier F, Belisle S, Robitaille D, Martineau R, Perrault LP, Hardy JF. Low-dose aprotinin is ineffective to treat excessive bleeding after cardiopulmonary bypass. Ann Thorac Surg 2000;69:452-6
26. Nielsen VG. Hemodilution modulates the time of onset and rate of fibrinolysis in human and rabbit plasma. J Heart Lung Transplant 2006;25:1344-52
27. Nielsen VG. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions. Blood Coagul Fibrinolysis 2007;18:647-56
28. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Innerhofer P. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. Br J Anaesth 2008;100:307-14
29. Sedrakyan A, Wu A, Sedrakyan G, Diener-West M, Tranquilli M, Elefteriades J. Aprotinin use in thoracic aortic surgery: safety and outcomes. J Thorac Cardiovasc Surg 2006;132:909-17
30. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001;92:855-62
31. Boldt J, Heesen M, Muller M, Pabsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996;83:254-61